KR900701323A - Ophthalmic preparation for the treatment of new glaucoma - Google Patents

Ophthalmic preparation for the treatment of new glaucoma

Info

Publication number
KR900701323A
KR900701323A KR1019900700030A KR900700030A KR900701323A KR 900701323 A KR900701323 A KR 900701323A KR 1019900700030 A KR1019900700030 A KR 1019900700030A KR 900700030 A KR900700030 A KR 900700030A KR 900701323 A KR900701323 A KR 900701323A
Authority
KR
South Korea
Prior art keywords
treatment
ophthalmic preparation
new glaucoma
glaucoma
new
Prior art date
Application number
KR1019900700030A
Other languages
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888811041A external-priority patent/GB8811041D0/en
Priority claimed from GB888822603A external-priority patent/GB8822603D0/en
Priority claimed from GB888829368A external-priority patent/GB8829368D0/en
Application filed filed Critical
Publication of KR900701323A publication Critical patent/KR900701323A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
KR1019900700030A 1988-05-10 1990-01-08 Ophthalmic preparation for the treatment of new glaucoma KR900701323A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888811041A GB8811041D0 (en) 1988-05-10 1988-05-10 Chemical compounds
GB888822603A GB8822603D0 (en) 1988-09-27 1988-09-27 Pharmaceutical compositions
GB888829368A GB8829368D0 (en) 1988-12-16 1988-12-16 Pharmaceutical compositions
PCT/DK1989/000112 WO1989010757A1 (en) 1988-05-10 1989-05-08 New ophthalmic preparation for treating glaucoma

Publications (1)

Publication Number Publication Date
KR900701323A true KR900701323A (en) 1990-12-01

Family

ID=27263899

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900700030A KR900701323A (en) 1988-05-10 1990-01-08 Ophthalmic preparation for the treatment of new glaucoma

Country Status (3)

Country Link
KR (1) KR900701323A (en)
AU (1) AU3693789A (en)
WO (1) WO1989010757A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645021A1 (en) * 1989-03-30 1990-10-05 Sanofi Sa USE OF A POTASSIC AGONIST IN THE TREATMENT OF GLAUCOMA
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
JPH08507773A (en) * 1993-03-15 1996-08-20 ビイク ネダーラント ベスローテン フェンノートシャップ Use of substituted alkyl nitrates for the treatment of pathologically high intraocular pressure
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
AU8561298A (en) * 1997-08-08 1999-03-01 Chugai Seiyaku Kabushiki Kaisha Remedies for complications of diabetes
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
AU771130B2 (en) 2000-01-18 2004-03-11 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US6548535B2 (en) 2000-01-18 2003-04-15 Merck & Co., Inc. Method for treating ocular hypertension
WO2003105724A2 (en) 2002-06-17 2003-12-24 Merck & Co., Inc. Novel maxi-k channel blockers, methods of use and process for making the same
US7196082B2 (en) 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
CA2505127A1 (en) 2002-11-08 2004-05-27 James B. Doherty Ophthalmic compositions for treating ocular hypertension
CN1791402A (en) 2003-03-27 2006-06-21 麦克公司 Ophthalmic compositions for treating ocular hypertension
EP1664011A4 (en) 2003-09-02 2009-02-25 Merck & Co Inc Ophthalmic compositions for treating ocular hypertension
BRPI0414102A (en) 2003-09-04 2006-10-31 Merck & Co Inc compound use and composition
WO2005025568A1 (en) 2003-09-04 2005-03-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO2006020003A2 (en) 2004-07-20 2006-02-23 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO2015117024A1 (en) 2014-01-31 2015-08-06 Mayo Foundation For Medical Education And Research Novel therapeutics for the treatment of glaucoma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
AU509591B2 (en) * 1976-04-02 1980-05-15 Chugai Seiyaku Kabushiki Kaisha Pyridine derivatives
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans

Also Published As

Publication number Publication date
AU3693789A (en) 1989-11-29
WO1989010757A1 (en) 1989-11-16

Similar Documents

Publication Publication Date Title
DK95091A (en) USE OF ACETYL-D-CARNITIN FOR THERAPEUTIC TREATMENT OF GLAUCOMA
NO904694L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES.
NO901684L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-SUBSTITUTED-2-OXINDOL DERIVATIVES.
KR900701323A (en) Ophthalmic preparation for the treatment of new glaucoma
DE69031908T2 (en) Artificial retina
ZA872624B (en) Medicament for the treatment of inflammations of the eye
DE69019774D1 (en) Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension.
NO914667D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLED DERIVATIVES
IT9041529A0 (en) DEVICE FOR THE SURGICAL CORRECTION OF AMETROPIA
FI91961C (en) Process for the preparation of (S) -ethyl-2-oxo-1-pyrrolidineacetamide
NO900697D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ACETAMIDE DERIVATIVES.
DK250088D0 (en) OPHTHALMOLOGICAL PREPARATION
IT1218565B (en) OCULAR TONOMETER
NO904800L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBAMATES.
NO920983D0 (en) PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS
NO905327L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBAMOIL OIL DERIVATIVES.
KR920700044A (en) Methods and means for inducing and preventing pupillary contraction of the eye
NO900972D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NAFTALEN DERIVATIVES.
NO900942D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AZACYCLOOKTADIEN DERIVATIVES.
NO890724D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAAZAACENAPYLENE DERIVATIVES.
NO890519D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PROPANON DERIVATIVES.
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ITMI910845A0 (en) OPHTHALMIC PREPARATIONS FOR THE TREATMENT OF GLAUCOMA
DE68906028D1 (en) USE OF ACETYL-D-CARNITIN FOR THE THERAPEUTIC TREATMENT OF GLAUCOMA.
NO891677D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENETANOLAMINE DERIVATIVES.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid